A Phase I Clinical Trial of DARC

NCT02394613 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Glaucoma
Ocular Hypertension
Glaucoma, Suspect

Interventions

DRUG: ANX776

Sponsor

University College, London

Collaborators

[object Object]